PTGS2 and atrial fibrillation: Additionally, PTGS2 in AF cells treated with E2 + LMHFV was upregulated versus the control (36 ± 46-fold, p = 0.062) and the LMHFV group (34 ± 1.7-fold, p < 0.05).